Why the study?
Does streptokinase reduce mortality and reinfarction compared to heparin in patients with recent myocardial infarction?
Population
764 patients suffering from myocardial infarction of less than 24 hours' duration
Comparison
Streptokinase standardized treatment lasting for… vs Heparin standardized treatment lasting for 24…
Design
RCT, Allocated at random
Follow-up
Average period of six weeks in hospital
Loading...
Supports streptokinase over heparin in recent MI; confirms mortality benefit in this RCT.
Does streptokinase reduce mortality and reinfarction compared to heparin in patients with recent myocardial infarction?
Streptokinase is superior to heparin in reducing hospital mortality and reinfarction rates in patients with recent myocardial infarction.
A 1971 study studied this question.